FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Penicillamine (Depen) Titratable Tablets
Status: Currently in Shortage
»Date first posted: 01/04/2018
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Inborn Errors; Pediatric; Renal; Rheumatology

Mylan Pharmaceuticals Inc. (Reverified 12/18/2018)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Penicillamine tablets, 250 mg (NDC 0037-4401-01) Unavailable. Expected recovery: Q3 2019. Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English